About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

TERMINATEDPhase 2NCT00515255

Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)

The purpose of this study is to investigate the effect of NPL-2003 on the symptoms of Obsessive Compulsive Disorder (OCD) in an adolescent population.

Lead sponsor: Neuropharm•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Neuropharm

Age

12 - 17 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Meets DSM-IV criteria for Obsessive Compulsive Disorder.
•CY-BOCS score of greater or equal to 16 at screening.
•NIMH Global OC Scale score of 7 or higher at screening.

Exclusion Criteria

•Patients planning to commence cognitive behaviour therapy during the period of the study or those who have begun cognitive behaviour therapy within 8 weeks prior to enrolment.
•Autistic Disorder or Pervasive Developmental Disorder.
•Moderate or severe mental retardation.
•Severe renal insufficiency.

Related studies

Developing Brain, Impulsivity and Compulsivity

NCT04631042 · Typical Development, Obsessive Compulsive Disorder, and more

The Effectiveness and Efficacy of an Online Cognitive Behavioral Psychotherapeutic Program

NCT07255131 · Depression - Major Depressive Disorder, Anxiety Chronic, and more

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

NCT04806620 · Post-Acute COVID-19 Syndrome, ME/CFS, and more

Precision Analytic Research Methods in OCD

NCT07011901 · Obsessive Compulsive Disorder

Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation

NCT06763081 · Behavioral Activation, Major Depressive Disorder, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 27, 2012Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment6

Start dateJul 2007

Last updatedApr 27, 2012

Condition

Obsessive Compulsive Disorder

Locations shown

New York State Psychiatric Institute, Columbia University

New York, New York

University Hospitals Case Medical Center

Cleveland, Ohio

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 27, 2012Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions